Ruifeng Hou
YOU?
Author Swipe
View article: [Treatment response of a two-dose regimen of dose-adjusted inotuzumab ozogamicin in relapsed/refractory B-cell acute lymphoblastic leukemia].
[Treatment response of a two-dose regimen of dose-adjusted inotuzumab ozogamicin in relapsed/refractory B-cell acute lymphoblastic leukemia]. Open
Objective: To observe the treatment response of a two-dose regimen of inotuzumab ozogamicin (inotuzumab), a monoclonal antibody targeting CD22, for patients with heavily treated relapsed/refractory B-cell acute lymphoblastic leukemia (R/R …
View article: Learnable PM diffusion coefficients and reformative coordinate attention network for low dose CT denoising
Learnable PM diffusion coefficients and reformative coordinate attention network for low dose CT denoising Open
Objective. Various deep learning methods have recently been used for low dose CT (LDCT) denoising. Aggressive denoising may destroy the edge and fine anatomical structures of CT images. Therefore a key issue in LDCT denoising tasks is the …
View article: CD7 CAR-T therapy for an AML patient with CD7 expression
CD7 CAR-T therapy for an AML patient with CD7 expression Open
To date, no ideal CAR-T product is available for treating acute myeloid leukemia (AML). Recently, CD7 CAR-T therapy has shown promising efficiency in treating T-cell acute lymphoblastic leukemia. Because the CD7 antigen is also expressed o…
View article: Intelligent anti‐epidemic mask based on KF and ECF fusion algorithm
Intelligent anti‐epidemic mask based on KF and ECF fusion algorithm Open
In response to environmental pollution and the spread of Coronavirus Disease 2019 (COVID‐19), this paper proposes a new type of smart mask design, and specifically proposes an optimized double closed‐loop control method, especially an impr…